Johnson & Johnson focuses on healthcare as its primary industry of service, providing medical devices for over 260 companies, pharmaceutical drugs such as Tylenol and Motrin, and over-the-counter medicines and products such as oral care, skin care, baby care, and first-aid. The company generates half of its revenue within the United States. It prides itself on its business structure, where its operations flow freely to the point of allowing management teams to have a wide range in making decisions. J&J has 260 companies in 60 countries selling their products around the world, with over 125 manufacturing facilities. The United States and Europe represent about three-quarters of the company's markets, distributing their products to retailers, wholesalers, and health care providers.
 

Operating for over 130 years, J&J seeks to impact how people heal through innovation. With more than 134,000 workers and a $20.4 billion net revenue in 2018, the company continues to work alongside innovators to provide healthcare solutions, including fighting against lung cancer, training doctors in the latest health care procedures, and developing products that can improve the way people live. By challenging science and medicine, Johnson & Johnson takes an unprecedented approach to how their products help consumers through utilizing the supply chain, developing research centers, and consistently publishing the latest in technology.